MDT

86.38

+0.14%↑

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

TLRY

6.45

-2.86%↓

MDT

86.38

+0.14%↑

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

TLRY

6.45

-2.86%↓

MDT

86.38

+0.14%↑

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

TLRY

6.45

-2.86%↓

MDT

86.38

+0.14%↑

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

TLRY

6.45

-2.86%↓

MDT

86.38

+0.14%↑

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

TLRY

6.45

-2.86%↓

Home・Stock List・Celldex Therapeutics Inc

Celldex Therapeutics Inc

Closed

SectorHealthcare

31.33 -0.03

Buy Sell

Overview

Share price change

24h

Current

Min

30.42

Max

31.55

Key metrics
By Trading Economics
Income	-14M -81M
Sales	75K 75K
EPS	-1.22
Profit margin	-108,422.667
Employees	198
EBITDA	-7.8M -81M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+71.85% upside

Dividends
By Dow Jones
Next Earnings	6 May 2026

Market Stats
By TradingEconomics
Market Cap	472M 2.1B
Previous open	31.36
Previous close	31.33

News Sentiment

By Acuity

100%

332 / 349 Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

18.91 / 20.63 Support & Resistance

Celldex Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

7 Apr 2026, 17:26 UTC

Major News Events

EIA Raises Oil-Price Forecasts as War in Middle East Continues

7 Apr 2026, 23:55 UTC

Market Talk

Genesis Energy Signals Higher Dividend Payout Ratios -- Market Talk

7 Apr 2026, 23:47 UTC

Market Talk

Major News Events

Market Talk Roundup: Latest on U.S. Politics

7 Apr 2026, 23:47 UTC

Market Talk

Major News Events

Precious Metals Rise, Boosted by Dollar Weakness, Lower Treasury Yields -- Market Talk

7 Apr 2026, 23:44 UTC

Market Talk

Major News Events

Gold Rallies as Trump Remarks Send Oil Prices Lower -- Market Talk

7 Apr 2026, 23:42 UTC

Market Talk

Global Equities Roundup: Market Talk

7 Apr 2026, 23:42 UTC

Market Talk

Nikkei Likely to Rise After Trump Agrees to Cease-Fire With Iran -- Market Talk

7 Apr 2026, 23:37 UTC

Market Talk

Major News Events

Oil Futures Fall After Trump Agrees to Two-Week Cease-Fire With Iran -- Market Talk

7 Apr 2026, 23:15 UTC

Market Talk

Major News Events

Markets Will Want Fast Evidence That Ships Are Moving -- Market Talk

7 Apr 2026, 23:04 UTC

Major News Events

Spot Gold Rises 2.5%, Spot Silver Climbs 4.9%

7 Apr 2026, 23:04 UTC

Major News Events

Precious Metals Rise After Trump Agrees to Ceasefire With Iran

7 Apr 2026, 23:03 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

7 Apr 2026, 23:03 UTC

Market Talk

Middle East Ceasefire Triggers Australian Dollar Rally -- Market Talk

7 Apr 2026, 23:01 UTC

Major News Events

Front-Month WTI Crude Oil Futures Falls 13.7% to $97.47 per Barrel

7 Apr 2026, 22:58 UTC

Major News Events

Front-Month Crude Oil Futures Slide After Trump Agrees to Cease-Fire With Iran

7 Apr 2026, 21:56 UTC

Acquisitions, Mergers, Takeovers

Telefónica Sells All Shares in Pegaso PCS, Celular de Telefonía

7 Apr 2026, 20:50 UTC

Market Talk

Major News Events

Basic Materials Roundup: Market Talk

7 Apr 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

7 Apr 2026, 19:45 UTC

Market Talk

Treasury Yields Mixed as Investors Brace for Iran Deadline -- Market Talk

7 Apr 2026, 19:17 UTC

Major News Events

The Risks to the Gulf Region's Oil Are Immense. Are Markets Shrugging Them Off? -- Barrons.com

7 Apr 2026, 19:16 UTC

Market Talk

Cold Shot Helps U.S. Natural Gas Futures Settle Higher -- Market Talk

7 Apr 2026, 19:07 UTC

Market Talk

Global Energy Roundup: Market Talk

7 Apr 2026, 19:07 UTC

Market Talk

Oil Futures Mixed Ahead of Trump's Iran Deadline -- Market Talk

7 Apr 2026, 18:41 UTC

Acquisitions, Mergers, Takeovers

Eldorado Gold: Total of 149.6M Common Shrs, Representing 75.31% of Votes Attached to All Outstanding Common Shrs, Were Voted >ELD.T

7 Apr 2026, 18:40 UTC

Acquisitions, Mergers, Takeovers

Eldorado Gold Holders Voted to Approve Issuance of Common Shrs in Connection With Proposed Plan of Arrangement With Foran Mining >ELD.T

7 Apr 2026, 18:39 UTC

Acquisitions, Mergers, Takeovers

Eldorado Gold Reports Voting Results From Special Meeting of Hldrs

7 Apr 2026, 18:24 UTC

Major News Events

Defense Stocks Can't Get a Boost From Iran War Escalations. What Would Move Them. -- Barrons.com

7 Apr 2026, 17:08 UTC

Market Talk

Latin America Less Exposed to Crude Supply Disruptions -- Market Talk

7 Apr 2026, 16:21 UTC

Major News Events

Defense Stocks Can't Get a Boost From Iran War Escalations. What Would Move Them. -- Barrons.com

7 Apr 2026, 16:20 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Health Care Roundup: Market Talk

Peer Comparison

Price change

Celldex Therapeutics Inc Forecast

Price Target

By TipRanks

71.85% upside

12 Months Forecast

Average 53.91 USD 71.85%

High 90 USD

Low 24 USD

Based on 12 Wall Street analysts offering 12 month price targets forCelldex Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

12 ratings

Buy

Hold

Sell

Based on 12 analysts giving stock ratings to Celldex Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

18.91 / 20.63Support & Resistance

Recent bullish events outweigh bearish events.

All events are bearish.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Celldex Therapeutics Inc

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.